Also trades as: 0JBU.L (LSE) · $vol 0M
NTLA NASDAQ
Intellia Therapeutics, Inc.
1W: -5.5%
1M: -25.4%
3M: -2.1%
YTD: +34.3%
1Y: +27.9%
3Y: -71.7%
5Y: -81.5%
$12.60
+0.23 (+1.86%)
Weekly Expected Move ±12.4%
$10
$12
$14
$15
$17
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$66M
Revenue
+45.0% YoY
$-395M
Net Income
+25.0% YoY
$-364M
Free Cash Flow
+4.6% YoY
85.4%
Gross Margin
-668.1%
Op. Margin
-639.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-51.1%
ROA-38.8%
ROIC-105.6%
Valuation
P/E-3.8
P/B2.4
EV/EBITDA-2.9
Leverage
Debt/Equity0.14
Current Ratio5.08
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z0.12
Beneish M-2.68